| pubmed-article:21535425 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21535425 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
| pubmed-article:21535425 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:21535425 | lifeskim:mentions | umls-concept:C0033975 | lld:lifeskim |
| pubmed-article:21535425 | lifeskim:mentions | umls-concept:C0233401 | lld:lifeskim |
| pubmed-article:21535425 | lifeskim:mentions | umls-concept:C0009244 | lld:lifeskim |
| pubmed-article:21535425 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:21535425 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:21535425 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:21535425 | pubmed:dateCreated | 2011-5-3 | lld:pubmed |
| pubmed-article:21535425 | pubmed:abstractText | Recently, cognitive therapy in people at ultra-high risk (UHR) for psychosis has been reported to show modest treatment benefits. The aim of this study was to assess the feasibility and efficacy of cognitive therapy in reducing psychiatric symptoms in UHR people in Korea. | lld:pubmed |
| pubmed-article:21535425 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21535425 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21535425 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21535425 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21535425 | pubmed:month | May | lld:pubmed |
| pubmed-article:21535425 | pubmed:issn | 1751-7893 | lld:pubmed |
| pubmed-article:21535425 | pubmed:author | pubmed-author:LeeEunE | lld:pubmed |
| pubmed-article:21535425 | pubmed:author | pubmed-author:KwonJun SooJS | lld:pubmed |
| pubmed-article:21535425 | pubmed:author | pubmed-author:ParkJin... | lld:pubmed |
| pubmed-article:21535425 | pubmed:author | pubmed-author:KimKyung... | lld:pubmed |
| pubmed-article:21535425 | pubmed:author | pubmed-author:AnSuk KyoonSK | lld:pubmed |
| pubmed-article:21535425 | pubmed:author | pubmed-author:LeeSu YoungSY | lld:pubmed |
| pubmed-article:21535425 | pubmed:author | pubmed-author:KangJee InJI | lld:pubmed |
| pubmed-article:21535425 | pubmed:author | pubmed-author:KimBo RaBR | lld:pubmed |
| pubmed-article:21535425 | pubmed:author | pubmed-author:ChoiSoo-HeeSH | lld:pubmed |
| pubmed-article:21535425 | pubmed:copyrightInfo | © 2011 Blackwell Publishing Asia Pty Ltd. | lld:pubmed |
| pubmed-article:21535425 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21535425 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:21535425 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21535425 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21535425 | pubmed:pagination | 174-8 | lld:pubmed |
| pubmed-article:21535425 | pubmed:meshHeading | pubmed-meshheading:21535425... | lld:pubmed |
| pubmed-article:21535425 | pubmed:meshHeading | pubmed-meshheading:21535425... | lld:pubmed |
| pubmed-article:21535425 | pubmed:meshHeading | pubmed-meshheading:21535425... | lld:pubmed |
| pubmed-article:21535425 | pubmed:meshHeading | pubmed-meshheading:21535425... | lld:pubmed |
| pubmed-article:21535425 | pubmed:meshHeading | pubmed-meshheading:21535425... | lld:pubmed |
| pubmed-article:21535425 | pubmed:meshHeading | pubmed-meshheading:21535425... | lld:pubmed |
| pubmed-article:21535425 | pubmed:meshHeading | pubmed-meshheading:21535425... | lld:pubmed |
| pubmed-article:21535425 | pubmed:meshHeading | pubmed-meshheading:21535425... | lld:pubmed |
| pubmed-article:21535425 | pubmed:meshHeading | pubmed-meshheading:21535425... | lld:pubmed |
| pubmed-article:21535425 | pubmed:meshHeading | pubmed-meshheading:21535425... | lld:pubmed |
| pubmed-article:21535425 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21535425 | pubmed:articleTitle | Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultra-high risk for psychosis. | lld:pubmed |
| pubmed-article:21535425 | pubmed:affiliation | Department of Psychiatry, Section of Affect and Neuroscience, Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul. | lld:pubmed |
| pubmed-article:21535425 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21535425 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:21535425 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
